Menu Back toSession 4 : QPPV Oversight: Interaction between QPPV and local QPPVs, Non-EU QPPV

Global Forum for Qualified Persons for Pharmacovigilance (QPPV)

15th Anniversary


Session 4 : QPPV Oversight: Interaction between QPPV and local QPPVs, Non-EU QPPV

Session Chair(s)

Maarten  Lagendijk, MSc

Maarten Lagendijk, MSc

  • Deputy EU QPPV
  • MSD B.V., Netherlands
Angela  Van Der Salm, PhD, MSc

Angela Van Der Salm, PhD, MSc

  • Director Pharmacovigilance, Managing partner
  • DADA Consultancy BV, Netherlands
In a global organisation, there are different regulatory expectations on a local level. How will the QPPV ensure oversight and communication with and between all local QPPVs and the global QP office? Can the PSMF be a tool to facilitate this oversight?

Speaker(s)

Sabine  Jeck-Thole, DrMed, MD

Globalising the PSMF – Tool for Global Understanding

Sabine Jeck-Thole, DrMed, MD

  • EU QPPV & Head Regional GPV EUCAN & EM
  • Boehringer Ingelheim International Gmbh, Germany
Ilaria  Grisoni

Interaction Between the Different Local QPPVs (EU and non-EU) and the EU QPPV

Ilaria Grisoni

  • Executive Director, Head of EU/International PV & Global Risk Management and EEA
  • Gentium Srl, A Jazz Pharmaceuticals Company, Italy
Yael  Troub, MPharm, MSc

Globalisation of Risk Minimisation with QPPV Involvement: Case Study - Local Signaling Efforts

Yael Troub, MPharm, MSc

  • Head of PV, ASR & Local QPPV
  • AbbVie, Israel